. Author manuscript; available in PMC: 2022 Feb 1.

Published in final edited form as: Pediatr Infect Dis J. 2021 Feb 1;40(2):e49–e55. doi: 10.1097/INF.0000000000002998

Table 4.

Comparison of SARS-CoV-2 positive and negative appendicitis patients by demographics, rupture, and days of GI symptoms prior to admission

	Appendiceal rupture			No rupture
	SARS-Cov-2 positive (n=5)	SARS-CoV-2 negative (n=22)	P value	SARS-Cov-2 positive (n=5)	SARS-CoV-2 Negative (n=39)	P value
Age (years) Mean ± SD	11.4 ± 5.98	11.0 ± 3.67	NS^a	9.75 ± 4.425	12.1 ± 4.90	NS^a
Gender No. (%)	M, 2 (40.0)	M, 15 (68.2)	NS^b	M, 4 (80.0)	M, 20 (51.3)	NS^b
Gender No. (%)	F, 3 (60.0)	F, 7 (31.8)	NS^b	F, 1 (20.0)	F, 19 (48.7)	NS^b
Ethnicity No. (%)	H, 5 (100)	H, 10 (45.5)	0.047^b	H, 4 (80.0)	H, 17 (43.6)	NS^b
Ethnicity No. (%)	Non-H, 0^c	Non-H, 12 (54.5)	0.047^b	Non-H, 1 (20.0)	Non-H, 22 (56.4)	NS^b
Days of GI symptoms PTA [Median (IQR)]	4 (2.5, 5)	2 (1, 3)	NS^d	1 (0.75, 2.5)	1 (1, 2)	NS^d

Student’s t test;

Fisher’s exact test;

P<0.05 adjusted residual post-hoc method;

Mann-Whitney rank sum test; GI, gastrointestinal; PTA, prior to admission; M, Male; F, Female; H, Hispanic; non-H, non-Hispanic; SD, standard deviation; IQR, interquartile range